Trade Brains

AUGUST 18, 2023

Best Vijay Kedia Portfolio Stocks: Many investors keep a close eye on stock buys and sales of ace investors for ideas and inspiration. In this article, we’ll look at the best Vijay Kedia portfolio stocks and see if they can be an interesting opportunity for us as well. Market Cap (Cr.) Who is Vijay Kedia? Net Profit Margin 15.6%

Portfolio 94

Portfolio Engineering Manufacturing Sales 94

Trade Brains

FEBRUARY 12, 2024

We will look at when were these Companies established, and what markets they cater to. Then let us look at their recent Annual earnings and what valuation are they currently at. The Company has been a pioneer in the field, creating a portfolio of over 470 Products, all derived from Natural Plant-based oils. Cr EPS ₹34.66

Manufacturing 59

Manufacturing Pharmaceutical Marketing Marketing 59

Trade Brains

JULY 13, 2023

CPL’s products are used in various industries including agrochemicals, automotive, food & beverages, cables & wires, chemicals & lubricants, pharmaceuticals, packaging, dairy, and more. Control Print is debt-free micro cap stock with a market valuation of Rs 1,053 crore. 932 EPS 195 Stock P/E 8 RoCE 20.6%

Pharmaceutical 52

Pharmaceutical Manufacturing Transportation Distribution 52

Trade Brains

APRIL 23, 2023

USL has a large portfolio of almost 80 brands including McDowell’s No.1, The spirits maker holds an impressive 32% market share in the nation and has over 47 sites and a widespread presence with 70,000+ outlets. Lately, it has also forayed into financial services setting up Airtel Payments Bank and offering credit cards.

Pharmaceutical 103

Pharmaceutical Banking Insurance Distribution 103

Trade Brains

NOVEMBER 24, 2023

The company serves its customers across industries like automotive, e-commerce, food delivery, transportation, and logistics, banking; financial services and insurance (BFSI), retail and quick service restaurants (QSR), telecom and utilities, healthcare and pharmaceuticals, government, railways, and waterways.

Planning 69

Planning B2C B2B Pharmaceutical 69

Trade Brains

FEBRUARY 2, 2024

In FY23, their revenue from healthcare services was 96.03%, drugs and pharmaceutical supplies were 2.34%, and other operating revenue (ancillary activities, service exports, sponsorship, and educational income) was 1.63%. They believe the stock is undervalued or the business is buoyant based on their assumptions and valuation.

Healthcare 59

Healthcare Wealth Management Insurance Financial Services 59

Brown Advisory

NOVEMBER 12, 2019

But as often is the case, the boom turned into a financial market bubble and the price/earnings ratio of the NRI 350 Index (a broad index of non-financial stocks) at the end of 1989 was over 50x, compared to the S&P 500® Industrial Index at 15x. PORTFOLIO IMPLICATIONS Confidence is a fragile and fuzzy notion.

Investing 52

Investing Investments Assets Economics 52